PKE Stock Analysis: Park Aerospace | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 732m USD | 12M Return: 106.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 10.8M
EPS Trend: 42.9%
Rev. Trend: 94.8%
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Park Aerospace Corp. (NYSE: PKE) is a U.S.-based aerospace company that develops and manufactures advanced composite materials, primarily film adhesives and hot-melt products, along with specialty ablative materials for rocket motors and radome applications. Its materials are used in primary and secondary structures for a broad range of aircraft, including large and regional transport jets, military aircraft, unmanned aerial vehicles, business jets, general aviation, and rotary wing platforms, with the company serving customers across North America, Asia, and Europe. Beyond materials, Park also designs and fabricates composite parts, structures, assemblies, and low-volume tooling for the aerospace industry. The company was incorporated in 1954, is headquartered in Westbury, New York, and was renamed from Park Electrochemical Corp. to Park Aerospace Corp. in July 2019 to better reflect its aerospace focus.
As a small-cap player in the GICS Aerospace & Defense sub-industry, Park operates in a sector characterized by long product qualification cycles and stringent certification requirements, which create high barriers to entry and tend to favor established suppliers. Its business model spans both upstream materials (resins, adhesives, lightning strike protection) and downstream parts and assemblies, giving it exposure to multiple tiers of the aerospace supply chain.
- Boeing 787 and Airbus A350 production rates drive adhesive demand
- Defense and space programs lift ablative radome materials revenue
- Special dividends signal management confidence in cash flow outlook
| Net Income: 12.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 3.14 > 1.0 |
| NWC/Revenue: 133.7% < 20% (prev 121.7%; Δ 12.06% < -1%) |
| CFO/TA 0.09 > 3% & CFO 12.6m > Net Income 12.7m |
| Net Debt (-89.1m) to EBITDA (17.0m): -5.25 < 3 |
| Current Ratio: 15.29 > 1.5 & < 3 |
| Outstanding Shares: last quarter (21.2m) vs 12m ago 6.31% < -2% |
| Gross Margin: 31.92% > 18% (prev 28.78%; Δ 3.15% > 0.5%) |
| Asset Turnover: 57.50% > 50% (prev 52.57%; Δ 4.94% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.71 (Total Current Assets 109.0m - Total Current Liabilities 7.13m) / Total Assets 144.4m |
| B: -0.33 (Retained Earnings -47.3m / Total Assets 144.4m) |
| C: 0.11 (EBIT TTM 15.1m / Avg Total Assets 132.5m) |
| D: 9.81 (Book Value of Equity 131.0m / Total Liabilities 13.4m) |
| Altman-Z'' = 14.62 = AAA |
| DSRI: 0.70 (Receivables 10.8m/13.0m, Revenue 76.2m/63.5m) |
| GMI: 0.90 (GM 28.78% / 31.92%) |
| AQI: 1.00 (AQ_t 0.09 / AQ_t-1 0.09) |
| SGI: 1.20 (Revenue 76.2m / 63.5m) |
| TATA: 0.00 (NI 12.7m - CFO 12.6m) / TA 144.4m) |
| Beneish M = -3.22 (Cap -4..+1) = AA |
As of July 28, 2026, the stock is trading at USD 36.08 with a total of 293,282 shares traded. Over the past week, the price has changed by +10.47%, over one month by -3.52%, over three months by +6.72% and over the past year by +106.39%.
Current recommended Stop Loss: 33.10 (which is 8.3% or 1.4 ATR below the current price).
Park Aerospace has no consensus analysts rating.
| Analysts Target Price | 42.5 | 17.8% |
P/E Trailing = 58.4333
P/E Forward = 17.094
P/S = 9.6044
P/B = 5.2472
P/EG = 1.4854
Revenue TTM = 76.2m USD
EBIT TTM = 15.1m USD
EBITDA TTM = 17.0m USD
Long Term Debt = 262k USD (estimated: total debt 307k - short term 45.0k)
Short Term Debt = 45.0k USD (from shortTermDebt, last quarter)
Debt = 307k USD (from shortLongTermDebtTotal, last quarter) (leases 317k already included)
Net Debt = -89.1m USD (calculated: Debt 307k - CCE 89.4m)
Enterprise Value = 642.9m USD (732.0m + Debt 307k - CCE 89.4m)
Interest Coverage Ratio = unknown (Ebit TTM 15.1m / Interest Expense TTM 0.0)
EV/FCF = 58.66x (Enterprise Value 642.9m / FCF TTM 11.0m)
FCF Yield = 1.70% (FCF TTM 11.0m / Enterprise Value 642.9m)
FCF Margin = 14.38% (FCF TTM 11.0m / Revenue TTM 76.2m)
Net Margin = 16.70% (Net Income TTM 12.7m / Revenue TTM 76.2m)
Gross Margin = 31.92% ((Revenue TTM 76.2m - Cost of Revenue TTM 51.9m) / Revenue TTM)
Gross Margin QoQ = 34.82% (prev 28.67%)
Tobins Q-Ratio = 4.45 (Enterprise Value 642.9m / Total Assets 144.4m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 307k)
Taxrate = 25.45% (4.34m / 17.1m)
NOPAT = 11.3m (EBIT 15.1m * (1 - 25.45%))
Current Ratio = 15.29 (Total Current Assets 109.0m / Total Current Liabilities 7.13m)
Debt / Equity = 0.00 (Debt 307k / totalStockholderEquity, last quarter 131.0m)
Debt / EBITDA = -5.25 (Net Debt -89.1m / EBITDA 17.0m)
Debt / FCF = -8.13 (Net Debt -89.1m / FCF TTM 11.0m)
Total Stockholder Equity = 118.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 9.60% (Net Income 12.7m / Total Assets 144.4m)
RoE = 10.75% (Net Income TTM 12.7m / Total Stockholder Equity 118.3m)
RoCE = 12.73% (EBIT 15.1m / Capital Employed (Equity 118.3m + L.T.Debt 262k))
RoIC = 8.43% (NOPAT 11.3m / Invested Capital 133.5m)
WACC = 8.75% (E(732.0m)/V(732.3m) * Re(8.75%) + D(307k)/V(732.3m) * Rd(0.0%) * (1-Tc(0.25)))
Discount Rate = 8.75% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 33.69 | Cagr: 1.88%
[DCF] Terminal Value 76.70% ; FCFF base≈8.72m ; Y1≈10.0m ; Y5≈14.7m
[DCF] Fair Price = 14.19 (EV 207.1m - Net Debt -89.1m = Equity 296.2m / Shares 20.9m; r=8.75% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 42.95 | EPS CAGR: 10.72% | SUE: N/A | # QB: 0
Revenue Correlation: 94.85 | Revenue CAGR: 12.67% | SUE: N/A | # QB: 0
EPS current Quarter (2026-08-31): EPS=0.14 | Chg30d=+3.85% | Revisions=+0% | Analysts=2
EPS next Quarter (2026-11-30): EPS=0.14 | Chg30d=+11.54% | Revisions=+0% | Analysts=2
EPS current Year (2027-02-28): EPS=0.62 | Chg30d=+4.17% | Revisions=+0% | GrowthEPS=+11.6% | GrowthRev=+0.0%
EPS next Year (2028-02-29): EPS=0.77 | Chg30d=+1.32% | Revisions=+0% | GrowthEPS=+23.2% | GrowthRev=+18.5%
[Analyst] Revisions Ratio: +0% (up=0, down=0)